Ipsen To Buy Five Products for $88M From Rival Sanofi

Source: Reuters

Feb 14, 2017

Ipsen has reached an agreement to buy five consumer healthcare products from French rival Sanofi for approximately $88 million.

The deal was spurred by requirements from the European Commission to sell certain assets from a previous deal between Sanofi and the German Boehringer Ingelheim.

Ipsen are acquiring Buscopan, Suppositoria Glycerini, Mucothiol, Mucodyne, and Prontalgine, a pain treatment that has grown at double-digit rates over the last four years.

In January, Ipsen bought Merrimack pancreatic cancer drug ONIVYDE.

Read the Reuters report

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments